The study assessed the safety and efficacy of intra-articular NASHA treatment compared to control saline injections, other hyaluronic acid products and other injectables including corticosteroids, platelet-rich plasma and mesenchymal stem cells in patients with knee osteoarthritis.
Patients reported sustained relief of knee osteoarthritis symptoms following a single NASHA injection. The researchers also observed a low incidence of treatment-related adverse events.
More articles on biologics:
Who are the 14 major players in the global spine biologics market?
Cerapedics i-FACTOR yields 50% fusion rate vs. 20% for allograft at 1-year follow-up — 3 insights
